CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 27 enrolled
Drug / intervention
Soy and Seleniumdietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00555386
NCT00555386N/ACompleted
CompareCT.gov

A Pilot Study to Determine the Effect of Dietary Intervention on Novel Biomarkers of Breast Cancer Risk.

University of East Anglia·interventional·Posted Nov 8, 2007·Updated Sep 25, 2008

In Brief

A clinical study evaluating Soy and Selenium for Breast Cancer Risk. Completed, enrolled 27 participants across 3 sites.

Detailed Summary

There is evidence to suggest that some dietary components can reduce the risk of breast cancer. In this pilot study two such components, isoflavones (compounds found in soy products) and selenium, will be given to women classed as at moderate to high risk of the disease. The aim is to determine some novel biomarkers of risk and to see the effect of supplementation on them.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer Risk
CountriesUnited Kingdom
CollaboratorsQuadram Institute Bioscience, Big C Local Cancer Research and Care, Clinical Research and Trials Unit (Norfolk & Norwich University Hospital, UK)

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 8, 2007
Enrollment StartApr 1, 2007
Primary CompletionMay 1, 2008
Study CompletionAug 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 18.7 years ago

Interventions

Soy and Seleniumdietary

6g of chocolate per day Control group with no supplementation Active group 50mg of soy protein isolate + 200µg selenium in the form of MSC